AppWizard
November 10, 2025
Tandem Diabetes Care, Inc. received FDA clearance for the Tandem Mobi mobile app for Android devices. The Tandem Mobi system is recognized as the world's smallest and most durable automated insulin delivery system, utilizing Control-IQ+ technology, which has shown 79% time in range and 90% overnight time in range. The app aims to enhance user engagement and communication between patients and healthcare providers. A limited release of the app is expected in December 2025, with full availability in early 2026, and it will be downloadable from the Google Play Store on compatible devices.
